Skip to main content

Table 4 Effect of decision aid and patient-provider discussions on patient intent for CHD risk reduction among those eligible for risk reduction

From: The effect of a decision aid intervention on decision making about coronary heart disease risk reduction: secondary analyses of a randomized trial

Planned CHD interventions

Control group

Intervention group

Adj. absolute difference between control and intervention, post visit(95% CI)*

 

Baseline (95% CI)

Post-visit (95% CI)

Baseline (95% CI)

Post-education (95% CI)

Post-values clarification (95% CI)

Post-coaching (95% CI)

Post-visit (95% CI)

Any effective CHD risk reducing Strategy† (n = 157)

25%

42%

28%

62%

61%

57%

63%

21%

(15-36%)

(32-52%)

(21-36%)

(50-75%)

(49-73%)

(45-69%)

(49-77%)

(5% to 37%)

BP med, if HTN (n = 55 )

3%

29%

11%

65%

65%

37%

26%

-3%

(0-11%)

(5-52%)

(0-24%)

(40-91%)

(45-86%)

(45-81%)

(7-45%)

(-30% to 25%)

Cholesterol med, if abnormal chol (n = 69)

12%

9%

5%

59%

59%

47%

39%

30%

(0-26%)

(1-18%)

(0-13%)

(43-75%)

(44%-74%)

(28-67%)

(24-54%)

(14% to 46%)

Smoking cessation, if smoking (n = 21)

60%

50%

82%

70%

80%

80%

80%

30%

(25-95%)

(8-92%)

(56-100%)

(35-100%)

(50-100%)

(50-100%)

(51-100%)

(-16% to 76%)

Aspirin, if CHD risk >6% and no contra-indication (n = 140)

12%

24%

14%

40%

40%

47%

43%

19%

(8-17%)

(14-33%)

(6-21%)

(27-54%)

(29-52%)

(31-63%)

(24-62%)

(-1% to39%)

Diet low in saturated fat, all (n = 157)

23%

40%

20%

  

46%

29%

-11%

(12-34%)

(29-51%)

(12-28%)

--

--

(44-65%)

(16-42%)

(-27% to 6%)

Exercise regularly, all (n = 157)

35%

54%

34%

--

--

56%

53%

-1

(24-47%)

(39-69%)

(23-45 %)

  

(42-69%)

(44-62%)

(-17 to 16)

  1. * Adjusted for random effects of clustering within provider.
  2. †Includes strategies that were the focus of our intervention: aspirin, blood pressure medicine, cholesterol medicine, smoking cessation.